succinylacetone has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohamed, S | 1 |
| Kambal, MA | 1 |
| Al Jurayyan, NA | 1 |
| Al-Nemri, A | 1 |
| Babiker, A | 1 |
| Hasanato, R | 1 |
| Al-Jarallah, AS | 1 |
1 other study available for succinylacetone and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy.
Topics: Cardiomyopathy, Hypertrophic; Cyclohexanones; Food, Formulated; Heptanoates; Homozygote; Humans; Hyd | 2013 |